The University of Kansas Cancer Center,10730 Nall Avenue — Overland Park, Kansas

The University of Kansas Cancer Center,10730 Nall Avenue is a clinical research site located in Overland Park, Kansas, United States 66211.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center,10730 Nall Avenue has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center,10730 Nall Avenue?

The University of Kansas Cancer Center,10730 Nall Avenue has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center,10730 Nall Avenue conducted?

The University of Kansas Cancer Center,10730 Nall Avenue has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive.

Is The University of Kansas Cancer Center,10730 Nall Avenue accredited by Crixeo Health?

The University of Kansas Cancer Center,10730 Nall Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center,10730 Nall Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.